Page 1

November 12 , 2021 To , BSE Limited , 25 , P. J. Towers , Dalal Street , Mumbai - 400 001 Ref : Company Scrip Code : 532834 Dear Sir / Madam , CFS Camlin Fine Sciences To , Listing Department , National Stock Exchange of India Ltd. , Exchange Plaza , Bandra Kurla Complex , Bandra ( East ) , Mumbai- 400051 Ref : Symbol : CAMLINFINE || Series : EQ Sub : Outcome of the Board Meeting This has reference to our intimation dated November 2 , 2021 . The Board of Directors of the Company at its meeting held today i.e. November 12 , 2021 , inter alia , approved the Unaudited Financial Results ( Standalone and Consolidated ) of the Company for the quarter and half - year ended September 30 , 2021 . A copy of the said Results along with the Limited Review Reports issued by the Statutory Auditors and operational highlights are enclosed herewith as Annexure 1 . The Board of Directors of the Company at its meeting held today also approved the appointment of Mr. Rahul Sawale as the Company Secretary & Compliance Officer of the Company w.e.f. November 12 , 2021. The details required under the SEBI ( Listing Obligations and Disclosure Requirements ) Regulations , 2015 are enclosed herewith as Annexure 2 . The Board meeting commenced at 10:00 a.m. ( IST ) and concluded at 4.30 p.m. ( IST ) . This is for your information and record please . Encl .: a / a Thanking You , For Camlin Fine Sciences Limited Santosh Parab Chief Financial Officer MUMBA SLTD Registered Office : Camlin Fine Sciences Ltd. F / 11-12 , WICEL , Opp . SEEPZ , Central Road , Andheri East , Mumbai 400 093 , India . CIN : L74100MH1993PLC075361 | ISO 22000 Certified Company +91 22 6700 1000 +91 22 2832 4404 corporate@camlinfs.com www.camlinfs.com